An Observational Study of Patients Treated With Bimatoprost 0.03% (Latisse®) for Hypotrichosis of the Eyelashes
- Conditions
- Eyelash Hypotrichosis
- Interventions
- Drug: bimatoprost 0.03%
- Registration Number
- NCT01623479
- Lead Sponsor
- Allergan
- Brief Summary
This is an observational study of patients treated with bimatoprost 0.03% (Latisse®) for at least 12 months for hypotrichosis of the eyelashes.
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- COMPLETED
- Sex
- All
- Target Recruitment
- 585
- Hypotrichosis of the eyelashes
- Using bimatoprost ophthalmic solution 0.03% (Latisse®) for at least 12 months
- Use of any over-the-counter medication(s) for eyelash growth
Study & Design
- Study Type
- OBSERVATIONAL
- Study Design
- Not specified
- Arm && Interventions
Group Intervention Description Hypotrichosis of the Eyelashes bimatoprost 0.03% Subjects with hypotrichosis of the eyelashes using bimatoprost 0.03% (Latisse®) as prescribed by physician for at least 12 months
- Primary Outcome Measures
Name Time Method Percentage of Subjects Satisfied With Latisse® Day 1 Overall subject satisfaction with Latisse® was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.
- Secondary Outcome Measures
Name Time Method Number of Applications of Latisse® Per Week Day 1 Number of applications of Latisse® per week as reported by the subjects.
Percentage of Subjects Satisfied Wtih Their Eyelashes Day 1 Overall subject satisfaction with their eyelashes was assessed on a 5-point scale (Very Satisfied, Satisfied, Neutral, Unsatisfied, and Very Unsatisfied). The percentage of subjects satisfied and very satisfied is reported.